Wu Capital

Nuvig Therapeutics is focused on developing innovative therapies aimed at restoring immune homeostasis and rebalancing immune function, particularly following inflammation. The company is building a pipeline of novel immune therapeutics specifically designed for chronic inflammatory and autoimmune diseases. By leveraging natural mechanisms to modulate immune responses, Nuvig seeks to enhance treatment options available to healthcare providers and improve patient outcomes.

Ray Therapeutics is a company focused on developing innovative optogenetic gene therapies aimed at treating patients with blinding diseases. By creating technology that enhances the understanding of rare retinal conditions, the company strives to empower healthcare professionals to effectively diagnose, cure, and manage inherited retinal diseases. Through its commitment to advancing optogenetics, Ray Therapeutics seeks to improve the quality of life for those affected by these debilitating conditions.

Rona Therapeutics is an RNA therapeutics platform focused on the discovery, development, and commercialization of innovative RNA medicines. The company specializes in modular and programmable RNA therapies, offering services that encompass oligonucleotide therapies, RNA editing, and polymeric molecules. Rona Therapeutics aims to create transformative RNA treatments that can significantly alter disease management across various therapeutic areas. To achieve this, the company is developing advanced facilities to enhance nucleic acid synthesis, delivery systems, oligonucleotide chemical modification, and RNA biology. By fostering an environment that promotes innovation, Rona Therapeutics is dedicated to improving patient outcomes and supporting healthier, longer lives.

Korro Bio Inc., established in 2018 and headquartered in Cambridge, Massachusetts, specializes in developing nucleic acid-based therapeutics targeting specific sequences in genetic code to treat rare diseases. The company's proprietary platform enables efficient and selective RNA editing, leveraging natural processes common to all multicellular organisms. Korro Bio aims to advance this technology to effect changes in protein structure and function across multiple tissues, expanding the reach of genetic medicines with additional precision and tunability by editing RNA instead of DNA.

RiVAI Technologies specializes in the development of advanced RISC-V based CPUs and customized System-on-Chip (SoC) designs. The company focuses on delivering high-performance computing solutions for diverse applications, ranging from edge computing to data centers. Additionally, RiVAI develops artificial intelligence chips tailored for Internet of Things (IoT) applications, catering to various sectors such as wearable technology, smart homes, security systems, agriculture, and consumer electronics. By offering low-power yet high-performance core processor chips, RiVAI enables its clients to meet the growing demands of modern computing environments.

Ranok Therapeutics is a biotechnology company focused on developing targeted protein degradation technology to discover and create new therapeutics. This innovative approach engages various biological processes and demonstrates superiority over existing targeted protein degradation methods. The company's pipeline includes both well-established and novel drug targets associated with cancer and other diseases that present significant unmet medical needs. Ranok is committed to advancing the next generation of cancer therapies that prioritize safety and effectiveness for patients facing serious health challenges.

FeiLiu Tech, established in 2016 in Shanghai, China, specializes in optimizing supply chain management for the garment industry. The company, founded by IBM Dr. Watson scientists, leverages artificial intelligence to connect key players in the supply chain, from fabric suppliers to brand owners, enhancing efficiency and continuity.

Laiye is a digital workforce platform that specializes in integrating artificial intelligence to enhance organizational productivity and creativity. The company offers a comprehensive automation process platform that includes capabilities such as robotic process automation (RPA) and intelligent document processing (IDP). Laiye's intelligent dialogue robot platform is designed to simulate human tasks, enabling automated processing of emails, documents, and report generation, as well as data entry into customer relationship management systems. By leveraging these technologies, Laiye helps enterprises streamline their operations, improve efficiency, and reduce operational costs.

Gemini Therapeutics, Inc. is a precision medicine company based in Cambridge, Massachusetts, founded in 2015. The company specializes in developing new therapies for patients experiencing dry age-related macular degeneration (AMD) and related rare genetic diseases. Gemini Therapeutics focuses on genetically defined conditions, creating therapeutic candidates that address molecular abnormalities in patients with significant clinical needs. Their diverse pipeline encompasses monoclonal antibodies, recombinant proteins, and gene therapies, positioning the company to potentially introduce first-in-class therapeutics. The development of these innovative treatment options is supported by collaborations with leading life science investors and academic institutions worldwide, reflecting a commitment to advancing medical care for individuals suffering from these conditions.

Medbanks Network Technology, founded in 2014 and based in Beijing, specializes in data processing services for the healthcare sector. The company focuses on developing an oncology database that compiles clinical and professional medical service information gathered from hospitals. This resource aims to enhance the understanding and management of cancer care. In addition, Sipai Health Technology Co Ltd operates within the medical technology and health management space in China, encompassing three main segments: specialty pharmacy, physician research assistance, and health insurance services. The specialty pharmacy segment is the primary revenue driver, while the company predominantly conducts its business within the People's Republic of China.

Inipharm Inc. is a biopharmaceutical company based in Bellevue, Washington, established in 2018. The company specializes in discovering and developing therapies for severe liver diseases, particularly nonalcoholic steatohepatitis (NASH). Inipharm focuses on small-molecule drugs that target HSD17B13, a gene linked to various liver conditions. By modulating this gene's activity, Inipharm aims to reduce liver damage, inflammation, and fibrosis, addressing significant unmet medical needs in the treatment of liver diseases.

Deptrum Limited, founded in 2018 by three scientists from Silicon Valley, specializes in developing optical technology and 3D vision solutions. Headquartered in Shanghai, with an additional location in Shenzhen, the company offers a full-stack solution that encompasses both hardware and software, leveraging nanophotonics and artificial intelligence to enhance machine perception of the 3D world. Deptrum's proprietary technology is designed for diverse applications across multiple sectors, including intelligent terminals, augmented and virtual reality, intelligent security, robotics, and automated medical devices. Their innovations include the world's first non-VCSEL structured light solution, which powers a variety of AIoT devices, such as mobile robots and AR devices, enabling enhanced interaction with the environment.

Korro Bio Inc., established in 2018 and headquartered in Cambridge, Massachusetts, specializes in developing nucleic acid-based therapeutics targeting specific sequences in genetic code to treat rare diseases. The company's proprietary platform enables efficient and selective RNA editing, leveraging natural processes common to all multicellular organisms. Korro Bio aims to advance this technology to effect changes in protein structure and function across multiple tissues, expanding the reach of genetic medicines with additional precision and tunability by editing RNA instead of DNA.

Citrine Medicine is a rare disease-focused pharmaceutical firm.

Akouos, Inc. is a biotechnology company based in Boston, Massachusetts, dedicated to developing gene therapies aimed at restoring, improving, and preserving hearing for individuals affected by various inner ear disorders. Founded in 2016, the company utilizes an innovative platform that includes a proprietary adeno-associated viral vector library and a unique delivery method. Its leading product candidate, AK-OTOF, targets hearing loss resulting from mutations in the OTOF gene. Akouos focuses on genetically-defined patient populations, addressing conditions ranging from single genetic mutations to hearing loss caused by ototoxic drugs and aging. The company has established strategic partnerships with key institutions, including Massachusetts Eye and Ear and Lonza, Inc., to advance its mission of providing precision genetic therapies for sensorineural hearing loss.

Laiye is a digital workforce platform that specializes in integrating artificial intelligence to enhance organizational productivity and creativity. The company offers a comprehensive automation process platform that includes capabilities such as robotic process automation (RPA) and intelligent document processing (IDP). Laiye's intelligent dialogue robot platform is designed to simulate human tasks, enabling automated processing of emails, documents, and report generation, as well as data entry into customer relationship management systems. By leveraging these technologies, Laiye helps enterprises streamline their operations, improve efficiency, and reduce operational costs.

PACT Pharma, Inc. is a biotechnology company focused on developing personalized cell-based therapies for cancer treatment, specifically through neoantigen-specific adoptive T-cell therapies aimed at solid tumors. The company utilizes bioinformatics to analyze the DNA and RNA of patients' tumors and normal tissues, identifying candidate neoantigen peptides that can stimulate targeted antitumor T-cell responses. By recognizing unique neo-epitopes associated with individual cancers, PACT Pharma enables the engineering of autologous T cells designed to specifically target and eliminate tumor cells expressing these neoantigens. Founded in 2016 and based in South San Francisco, California, PACT Pharma is dedicated to advancing innovative treatment options for patients with cancer.

Medbanks Network Technology, founded in 2014 and based in Beijing, specializes in data processing services for the healthcare sector. The company focuses on developing an oncology database that compiles clinical and professional medical service information gathered from hospitals. This resource aims to enhance the understanding and management of cancer care. In addition, Sipai Health Technology Co Ltd operates within the medical technology and health management space in China, encompassing three main segments: specialty pharmacy, physician research assistance, and health insurance services. The specialty pharmacy segment is the primary revenue driver, while the company predominantly conducts its business within the People's Republic of China.

Loving Care International Pet Hospital is a comprehensive animal medical institution that operates a chain of clinics and hospitals focused on pet healthcare services. The facility offers a range of services including beauty treatments, physical examinations, vaccinations, and clinics. In addition to standard medical care, Loving Care provides users with information on the prevention of common diseases in dogs and cats, as well as alternative pet health issues. The establishment also operates mobile animal service vehicles to deliver home-based basic medical services, ensuring that pets receive the care they need in a convenient manner. Through its commitment to improving the diagnosis and treatment of pet diseases, including serious conditions such as tumors, Loving Care aims to enhance the overall well-being of animals and support pet owners in maintaining their pets' health.

Laiye is a digital workforce platform that specializes in integrating artificial intelligence to enhance organizational productivity and creativity. The company offers a comprehensive automation process platform that includes capabilities such as robotic process automation (RPA) and intelligent document processing (IDP). Laiye's intelligent dialogue robot platform is designed to simulate human tasks, enabling automated processing of emails, documents, and report generation, as well as data entry into customer relationship management systems. By leveraging these technologies, Laiye helps enterprises streamline their operations, improve efficiency, and reduce operational costs.

Deptrum Limited, founded in 2018 by three scientists from Silicon Valley, specializes in developing optical technology and 3D vision solutions. Headquartered in Shanghai, with an additional location in Shenzhen, the company offers a full-stack solution that encompasses both hardware and software, leveraging nanophotonics and artificial intelligence to enhance machine perception of the 3D world. Deptrum's proprietary technology is designed for diverse applications across multiple sectors, including intelligent terminals, augmented and virtual reality, intelligent security, robotics, and automated medical devices. Their innovations include the world's first non-VCSEL structured light solution, which powers a variety of AIoT devices, such as mobile robots and AR devices, enabling enhanced interaction with the environment.

Sanjieke is an online education platform based in China that focuses on providing vocational training and corporate education for IT professionals. The company offers a variety of courses aimed at enhancing professional growth by delivering industry-specific knowledge and skills that are often not available through traditional universities. By catering to the evolving demands of the market, Sanjieke's platform helps individuals develop competencies that are crucial for success in the technology sector.

Cassia Networks is a wireless telecommunications company specializing in Bluetooth technology aimed at enhancing connectivity within Internet of Things (IoT) applications. Founded in 2014 by Felix Zhao, the company develops innovative solutions to address the challenges of IoT connectivity and management. Its product line includes the Cassia Hub Bluetooth router, which is recognized as the world's first Bluetooth router capable of remotely controlling up to 22 Bluetooth devices over long distances. Other offerings include a Bluetooth smart plug, multi-color LED lights, personal safety sensors, and Bluetooth speakers. With offices in Silicon Valley and Beijing, Cassia Networks strives to simplify IoT integration by allowing users to manage multiple Bluetooth devices from anywhere, overcoming the traditional limitations of short-range controls.

Smart Bees is a developer of innovative foldable furniture designed for small living spaces, primarily targeting consumers in China. The company focuses on creating high-quality, environmentally safe furniture that embodies fashion and simplicity. By prioritizing intelligent design, Smart Bees aims to provide practical solutions for individuals seeking stylish and functional furnishings for compact environments.

Cobo is a leading provider of digital asset custody solutions, founded in 2017 and headquartered in Singapore. The company specializes in creating secure and efficient management systems for digital assets, catering primarily to institutional clients. Cobo offers an omni-custody platform that includes a range of custody technologies, such as full custody utilizing bank-grade hardware security modules, co-managed custody based on advanced multi-party computation, and fully decentralized self-custody through smart contracts. Additionally, Cobo provides services like Wallet-as-a-Service and SuperLoop, an off-exchange settlement network. With over 500 institutional clients and billions of dollars in assets under custody, Cobo serves a diverse clientele that includes exchanges, investment funds, and traditional financial institutions across multiple regions. The company emphasizes security and regulatory compliance, holding SOC 2 certification and licenses in several jurisdictions, including the United States and Singapore. Cobo has garnered support from prominent global investors, further solidifying its position in the digital asset management space.

Meng Fan Japanese is an online education platform.

Newtop100.com is a media and entertainment company based in Beijing, China, founded in 2016. It specializes in publishing news reports and conducting interviews with leaders in the new economy, focusing on innovative technologies and emerging business models. Through various audio and digital media platforms, Newtop100.com provides in-depth coverage and analysis of over 100 leading companies, allowing clients to explore investment opportunities within this dynamic sector. The company aims to highlight pioneers in different domains of the new economy, facilitating informed decisions for investors and stakeholders alike.

Kangaroo Mama is a childcare service provider based in Shanghai, China, specializing in professional daycare for children up to three years old. Founded in 2016, the company addresses the needs of working parents in first-tier cities by offering a range of services, including infant care, evening care for children aged three to six, and temporary care during summer and winter vacations. Kangaroo Mama focuses on fostering cognitive, language, awareness, and social skills in young children, ensuring a reliable and beneficial environment for their development.

Roadstar.AI is a startup based in Silicon Valley and Shenzhen, founded by experts in robotics and machine learning with backgrounds from prominent tech companies. The company specializes in autonomous driving technology aimed at enhancing transportation systems. Its innovative approach leverages a multi-sensor fusion framework that ensures precise time and spatial synchronization, enabling real-time updates and robust data extraction. By integrating artificial intelligence into vehicles, Roadstar.AI aspires to create safer, more efficient, and enjoyable travel experiences for all users.

Youyang Media operates an education content sharing platform aimed at parents of children up to twelve years old. Founded in 2016 and based in Beijing, China, the company offers a variety of parenting resources, including personalized childcare knowledge videos, virtual and augmented reality content, and systematic original parenting videos. Its platform also features offline activities designed to enhance parent education and provide growth resources and educational products. By focusing on engaging and informative content, Youyang seeks to support parents in their childcare journey.

Laiye is a digital workforce platform that specializes in integrating artificial intelligence to enhance organizational productivity and creativity. The company offers a comprehensive automation process platform that includes capabilities such as robotic process automation (RPA) and intelligent document processing (IDP). Laiye's intelligent dialogue robot platform is designed to simulate human tasks, enabling automated processing of emails, documents, and report generation, as well as data entry into customer relationship management systems. By leveraging these technologies, Laiye helps enterprises streamline their operations, improve efficiency, and reduce operational costs.

Semma Therapeutics, Inc. is a biotechnology company based in Cambridge, Massachusetts, focused on developing innovative cell therapies for patients with Type 1 diabetes. Founded in 2014, the company is dedicated to creating a transformative treatment that addresses the need for insulin injections by generating functional, insulin-producing beta cells through a proprietary method licensed from the laboratory of Professor Douglas Melton. Semma Therapeutics aims to combine these engineered cells with advanced devices to offer a potential replacement for the missing beta cells in diabetic patients, eliminating the need for immunosuppression. The company's ongoing research seeks to bring this novel therapeutic option to clinical settings, ultimately improving the lives of individuals living with diabetes.

Horizon Robotics is a prominent provider of advanced driver assistance systems (ADAS) and autonomous driving solutions specifically designed for passenger vehicles. The company develops proprietary software and hardware that integrate advanced algorithms and specialized processing capabilities. These technologies form the foundation for enhanced driving automation, aiming to improve both safety and the overall experience for drivers and passengers. By focusing on innovative solutions, Horizon Robotics plays a key role in the evolution of assisted and autonomous driving.

Yunding Network Technology is a developer of smart home security systems, specializing in smart locks in the smart apartment segment under its brands Loock and Yunding.

Liulishuo is a leading artificial intelligence-driven educational technology company founded in September 2012 by Dr. Wang Wei and Dr. Hu Zhe and Dr. Lin Hui. Liulishuo offers a personalized and adaptive language learning experience to 50 million learners in 379 cities in China and over 175 countries around the world. Its self-developed artificial intelligence English teacher, based on deep learning technology, can provide personalized and adaptive learning courses for each user.

Namihe is a digital textbook and smart reading service platform that offers rich reading content and creates a range of reading settings for kids between the ages of 6 and 15. They provide a learning tool for the school students.

Cui Yutao Health Management Center specializes in the development of a comprehensive health management platform focused on children's physical and mental well-being. The center provides a mobile application that offers daily health records, an online parenting community, and expert guidance for child health management. It also facilitates access to medical assistance and child health insurance services. Through these offerings, parents can obtain valuable information related to childcare, including medical advice, early-stage education, and infant products, thereby enhancing pediatric care and supporting the health needs of children.

Horizon Robotics is a prominent provider of advanced driver assistance systems (ADAS) and autonomous driving solutions specifically designed for passenger vehicles. The company develops proprietary software and hardware that integrate advanced algorithms and specialized processing capabilities. These technologies form the foundation for enhanced driving automation, aiming to improve both safety and the overall experience for drivers and passengers. By focusing on innovative solutions, Horizon Robotics plays a key role in the evolution of assisted and autonomous driving.

Cui Yutao Health Management Center specializes in the development of a comprehensive health management platform focused on children's physical and mental well-being. The center provides a mobile application that offers daily health records, an online parenting community, and expert guidance for child health management. It also facilitates access to medical assistance and child health insurance services. Through these offerings, parents can obtain valuable information related to childcare, including medical advice, early-stage education, and infant products, thereby enhancing pediatric care and supporting the health needs of children.

Apricot Forest operates a mobile application designed for Chinese doctors, offering access to patient records, medical journals, and discussion boards. The platform aims to enhance the clinical practice by combining scientific resources with a humanistic approach, thereby improving efficiency and productivity in healthcare settings. By facilitating easier access to essential medical information and fostering professional discussions, Apricot Forest seeks to support doctors in delivering high-quality medical care.

XiaoHongChun, established in April 2015, operates as a fashion and beauty business platform that primarily targets young women. The company is known for its Xiaohonglip app, which focuses on cosmetics video sharing, helping consumers navigate beauty products. In addition to its app, XiaoHongChun engages in internet celebrity brokerage and manages beauty brand operations. The company also facilitates cross-border e-commerce supply chains, enhancing social interactions in the beauty and fashion sectors while offering valuable shopping guidance to its users.

Qianding is the development of smart cities and communities. They focus on intelligent solutions for communities, parks, businesses, apartments, and other spaces. They provide services like integrated service reconstruction. They offer smart community management, smart access control, and smart community solutions. They empower ecological integration to promote synergy and sustainable development.